Genmab — December 2019
-
Genmab A/SRealtidskurs
Forandring
-0.88%Senest1 461,50 DKK
Køb
Sælg
Læs mere
GENMAB NÆRMER SIG NY GODKENDELSE AF DARZALEX-KOMBINATION I EUROPA12:50
Genmab har sammen med sin partner Janssen fået de europæiske lægemiddelmyndigheders opbakning til at udvide brugen af kræftmidlet Darzalex til behandling af knoglemarvskræft.Udvalget for humanmedicinske lægemidler, CHMP, anbefaler en godkendelse af Darzalex i kombination med kræftmidlet Velcade, kemoterapiformen Thalidomid og hormonpræpar
-
Donald J. Trump
@realDonaldTrump
·
3 min
We have agreed to a very large Phase One Deal with China. They have agreed to many structural changes and massive purchases of Agricultural Product, Energy, and Manufactured Goods, plus much more. The 25% Tariffs will remain as is, with 7 1/2% put on much of the remainder.... -
Donald J. Trump
@realDonaldTrump
·
4 min
.....The Penalty Tariffs set for December 15th will not be charged because of the fact that we made the deal. We will begin negotiations on the Phase Two Deal immediately, rather than waiting until after the 2020 Election. This is an amazing deal for all. Thank you! -
Det er nu ikke noget markederne reagerer på.
-
CANDOR study: should Dara-Kd become the new SOC for len refractory patients with RRMM? https://www.youtube.com/watch?v=Yhj_rwxWt60
-
Thanks E L. I have put your link in the debat: https://www.proinvestor.com/index.php?p=debat_1&postid=80141
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind